Biocon Biologics has secured a credit rating upgrade from S&P Global Ratings to BB+, reflecting a simpler capital structure, improved financial discipline, and steady growth outlook in the global biosimilars market.
Piramal Pharma said it is seeing early signs of recovery in its CDMO business, driven by higher RFP activity and improving US biotech funding, even as inventory destocking continued to weigh on Q3FY26 results.c
.png)
Eli Lilly has entered a deal worth up to $1.12 billion with gene-editing firm Seamless Therapeutics, signaling a major push into advanced genetic treatments for hearing loss and rare diseases.
Zydus Lifesciences said its Ankleshwar manufacturing facility received three observations from the USFDA after a recent inspection, adding that none of the findings were linked to data integrity issues.
Wellness initiatives enhance employee performance by improving health focus and engagement while fostering long-term community health through reduced disease burdens and stronger social ties.
Merck has partnered with a global health coalition to improve access to its Ebola vaccine, aiming to reduce costs and ensure availability in regions most affected by the virus. The initiative focuses on saving lives and controlling outbreaks.
Abbott has received CE Mark approval for its TactiFlex Duo Ablation Catheter in Europe, marking a major step forward in AFib treatment with dual-energy technology and successful first commercial cases.
Dentalkart partners with NSK Japan to offer authentic dental equipment in India with transparent pricing and faster after-sales support.
GSK has agreed to acquire RAPT Therapeutics for $2.2 billion, adding ozureprubart, a long-acting anti-IgE antibody, to its pipeline and strengthening its push into food allergy treatment.
Boston Scientific Corporation has signed a definitive agreement to acquire US-based medical device company Penumbra Inc. in a transaction valued at approximately $14.5 billion, strengthening its presence in vascular and neurovascular therapi...
, CDSCO.jpg)